Greenfield Savings Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
Greenfield Savings Bank's PFE Position: Q2 2026 in Review
Greenfield Savings Bank reduced its Pfizer (PFE) stake by 5.8% in Q2 2026, selling an estimated $49.9K and leaving 31,225 shares worth $752K. The position accounts for 0.29% of the portfolio, ranked #85.
Greenfield Savings Bank first reported a position in PFE in Q2 2022 and has held it in 17 quarters since. The position peaked at $2.35M in Q2 2022. 1,484 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Greenfield Savings Bank held 31,225 shares of Pfizer worth $752K as of Q2 2026.
- Greenfield Savings Bank sold 1,906 Pfizer shares in Q2 2026, an estimated $49.9K.
- Pfizer made up 0.29% of Greenfield Savings Bank's portfolio in Q2 2026, its #85 holding.
- Greenfield Savings Bank first reported a position in Pfizer in Q2 2022 and has held it in 17 quarters since.
- Greenfield Savings Bank's Pfizer position peaked at $2.35M in Q2 2022.
- 1,484 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Greenfield Savings Bank's 13F filing for Q2 2026, filed 7 Jul 2026.